Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Pregnant individuals who contract COVID-19 face a higher risk of having a preterm birth, according to researchers at The University of California, San Francisco (UCSF).
Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
Here, we discover what we need to know about addressing the increased financial risk from the global COVID-19 pandemic, starting with the background and challenges faced.
According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.
Dr Tedros Ghebreyesus, WHO leader, asked richer countries in the Global North to wait before giving third COVID jabs - as the Global South is yet to hit 10% double-vaccinated, due to low vaccine supply.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.
Abhishek Goel, CEO, Cactus Communications, addresses the economic and mental health fallout of the pandemic and how AI can improve engagement with employees and monitor their wellbeing.
A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.
A study, published in the journal DNA Repair, finds that hydroxychloroquine (HCQ) is potentially toxic to mammals - the drug that was previously elevated to the status of miracle COVID cure in some circles.
